New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Body Fat Without Loss of Muscle Mass The natural GLP-1 activator is clinically shown to support fat loss, including visceral fat reduction, while preserving lean muscle AUCKLAND, New Zealand, July 23, 2026 --(BUSINESS WIRE)--Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, announces today the publication of a new clinical study in US medical journal, Obesity Pillars, demonstrating Calocurb's effectiveness in weight loss and muscle preservation
Johns wort, or evening primrose oil, but check with your doctor first, as they may interfere with other medications youre taking or affect other medical conditions
Tradjenta works at the molecular and hormonal level through the following sequence: DPP-4 Enzyme Inhibition: Linagliptin binds to the DPP-4 enzyme, blocking its ability to break down natural GLP-1 and GIP hormones
However, "better" depends on the individual
Weight loss: Varies